QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced plans to advance its QuantiFERON latent tuberculosis (TB) test with a new fully automated Sample to Insight workflow and a ...
Researchers from the QIMR Berghofer Medical Research Institute in Australia have described the development of a melanoma risk stratification tool based on self-reported patient information that is ...
Credit: Getty Images Investigators compared 9 risk stratification tools, including risk grouping systems, risk scores, and nomograms. Current prostate cancer (PCa) risk stratification tools perform ...
The US FDA has granted De Novo marketing authorization for ArteraAI Prostate (Artera, Los Altos, California), a novel artificial intelligence (AI)-powered risk-stratification tool for patients with ...
Currently, numerous systems exist for the identification of high-risk prostate cancer, but few of these systems can guide treatment strategies. A new stratification tool that uses common diagnostic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results